Copyright
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Aug 6, 2024; 12(22): 4859-4864
Published online Aug 6, 2024. doi: 10.12998/wjcc.v12.i22.4859
Published online Aug 6, 2024. doi: 10.12998/wjcc.v12.i22.4859
Bridging the gap in cardiac mass diagnosis: Advanced imaging, genetic associations, and biomarkers
Yi-Hao Loh, School of Medicine, School of Medicine, Zhejiang University, China, Hangzhou 310000, Zhejiang Province, China
Xu-Lin Hong, Department of Cardiology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou 310000, Zhejiang Province, China
Author contributions: Loh YH and Hong XL contributed to this paper; Loh YH originated the overall concept and manuscript outline, and contributed to the manuscript writing; Hong XL provided critical revisions; Loh YH and Hong XL edited the manuscript.
Conflict-of-interest statement: The authors declare that they have no conflict of interest to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Xu-Lin Hong, MD, Doctor, Department of Cardiology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, No. 3 East Qingchun Road, Hangzhou 310000, Zhejiang Province, China. 1028346604@zju.edu.cn
Received: March 11, 2024
Revised: May 4, 2024
Accepted: June 3, 2024
Published online: August 6, 2024
Processing time: 112 Days and 18.1 Hours
Revised: May 4, 2024
Accepted: June 3, 2024
Published online: August 6, 2024
Processing time: 112 Days and 18.1 Hours
Core Tip
Core Tip: The diagnosis of cardiac masses can be challenging because of their frequent atypical manifestations. Accurate differentiation between a thrombus, vegetation, and tumor requires a comprehensive approach that integrates imaging techniques, biomarkers, genetic testing, and a detailed medical history. The management strategies for these masses can vary significantly depending on the diagnosis, which has a direct impact on therapeutic outcomes.